Glenmark Pharma launches Calcium Gluconate Injection in USA

Glenmark Pharma launches Calcium Gluconate Injection in USA. The product is approved by the USFDA and targets the injectable generics market. Launch includes three dosage forms — 1,000 mg/10 mL, 5,000 mg/50 mL, and 10,000 mg/100 mL. This strengthens Glenmark’s presence in the US hospital generics segment.
📊 STOCKS: GLENMARK | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Pharma